Paricalcitol Therapy Improves Hyperparathyroidism in Patients with X-Linked Hypophosphatemia: Results from a One-Year Randomized Controlled Trial

被引：0
|
作者：
Carpenter, Thomas [1 ]
Olear, Elizabeth A. [1 ]
Zhang, Jane H. [2 ]
Ellis, Bruce K. [1 ]
Simpson, Christine A. [1 ]
Cheng, David [1 ]
Gundberg, Caren M. [1 ]
Insogna, Karl [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] VA Connecticut Healthcare Syst, West Haven, CT USA
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-0209
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Hyperparathyroidism in Patients With X-Linked Hypophosphatemia
    Lecoq, Anne-Lise
    Chaumet-Riffaud, Philippe
    Blanchard, Anne
    Dupeux, Margot
    Rothenbuhler, Anya
    Lambert, Benoit
    Durand, Emmanuel
    Boros, Erika
    Briot, Karine
    Silve, Caroline
    Francou, Bruno
    Piketty, Marie
    Chanson, Philippe
    Brailly-Tabard, Sylvie
    Linglart, Agnes
    Kamenicky, Peter
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (07) : 1263 - 1273
  • [2] Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients
    DeLacey, Sean
    Liu, Ziyue
    Broyles, Andrea
    El-Azab, Sarah A.
    Guandique, Cristian F.
    James, Benjamin C.
    Imel, Erik A.
    BONE, 2019, 127 : 386 - 392
  • [3] Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia
    Martin Ramos, Silvia
    Gil-Calvo, Marta
    Roldan, Virginia
    Castellano Martinez, Ana
    Santos, Fernando
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [4] Effect of Paricalcitol on Circulating Parathyroid Hormone in X-Linked Hypophosphatemia: A Randomized, Double-Blind, Placebo-Controlled Study
    Carpenter, Thomas O.
    Olear, Elizabeth A.
    Zhang, Jane H.
    Ellis, Bruce K.
    Simpson, Christine A.
    Cheng, David
    Gundberg, Caren M.
    Insogna, Karl L.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (09): : 3103 - 3111
  • [5] Dental health of patients with X-linked hypophosphatemia: A controlled study
    Larsson, Amila
    Regnstrand, Tobias
    Skott, Pia
    Makitie, Outi
    Bjornsdottir, Sigridur
    Garming-Legert, Karin
    FRONTIERS IN ORAL HEALTH, 2023, 4
  • [6] Tertiary hyperparathyroidism in two paediatric patients with X-linked hypophosphatemia during Burosumab treatment
    Padidela, Raja
    Rayner, Lauren
    Boot, Annemieke M.
    BONE, 2025, 190
  • [7] EFFECTS OF CALCITRIOL AND PHOSPHORUS THERAPY ON THE GROWTH OF PATIENTS WITH X-LINKED HYPOPHOSPHATEMIA
    FRIEDMAN, NE
    LOBAUGH, B
    DREZNER, MK
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (04): : 839 - 844
  • [8] One year of Burosumab in a Girl with X-Linked Hypophosphatemia who received previously Conventional Therapy, Clinic Case
    Tau, Cristina Catalina
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 213 - 213
  • [9] One-Year Results of an Educational Program on Osteoarthritis: A Prospective Randomized Controlled Trial in Brazil
    de Rezende, Marcia Uchoa
    Hissadomi, Marcelo Issao
    de Campos, Gustavo Constantino
    Frucchi, Renato
    Pailo, Alexandre Felicio
    Pasqualin, Thiago
    Rocha Brito, Nadia Lucila
    Magashima Santana, Olga Fugiko
    Moreira, Merilu Marins
    Strutz, Carolina Guimaraes
    dos Santos Matos, Natalia Beraldo
    de Camargo, Olavo Pires
    Hernandez, Arnaldo Jose
    GERIATRIC ORTHOPAEDIC SURGERY & REHABILITATION, 2016, 7 (02) : 86 - 94
  • [10] Switching to burosumab from conventional therapy in siblings with relatively well-controlled X-linked hypophosphatemia
    Senoo, Shintaro
    Fujimoto, Masanobu
    Yamaguchi, Yukiko
    Osaki, Mari
    Hanaki, Keiichi
    Namba, Noriyuki
    CLINICAL PEDIATRIC ENDOCRINOLOGY, 2024, 33 (01) : 27 - 34
12345